PSA ≤0.1ng/ml after radiotherapy as predictive treatment results in prostate cancer patients

被引：0
|
作者：
Munoz Garcia, J. L. [1 ]
Ropero Carmona, M. F. [1 ]
Cruz Munoz, M. C. [1 ]
Gonzalez Ruiz, M. A. [1 ]
Simon Silva, P. [1 ]
Quiros Rivero, J. [1 ]
Rios Kavadoy, Y. [1 ]
Corbacho Campos, A. [1 ]
Cabrera Rodriguez, J. J. [1 ]
机构：
[1] Infanta Cristina Univ Hosp, Radiat Oncol, Badajoz, Spain
来源：
RADIOTHERAPY AND ONCOLOGY | 2018年 / 127卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1547
引用
收藏
页码：S835 / S835
页数：1
相关论文
共 50 条
  • [1] Results of combined radiotherapy and hormonal treatment of prostate cancer patients with initial PSA value >40 ng/ml
    Jiri, Kubes
    Jakub, Cvek
    Vladimir, Vondracek
    Jan, Dvorak
    Sona, Argalacsova
    Matej, Navratil
    Jan, Buril
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2012, 17 (02) : 79 - 84
  • [2] BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: IS EVERY PATIENT WITH A PSA OF 0.1NG/ML REALLY RECURRING?
    Schiffmann, Jonas
    Eichenauer, Till
    Tennstedt, Pierre
    Steuber, Thomas
    Michl, Uwe
    Heinzer, Hans
    Graefen, Markus
    Budaeus, Lars
    JOURNAL OF UROLOGY, 2014, 191 (04): : E660 - E660
  • [3] The PSA nadir coal for radiotherapy of prostate cancer is ≤0.2 ng/ml
    Critz, FA
    Levinson, AK
    Williams, WH
    Holladay, DA
    Holladay, CT
    Griffin, VD
    JOURNAL OF UROLOGY, 1998, 159 (05): : 218 - 218
  • [4] Results of transrectal focussed ultrasound for the treatment of localized prostate cancer (120 patients with PSA ≤ 10 ng/ml)
    Poissonnier, L
    Gelet, A
    Chapelon, JY
    Bouvier, R
    Rouviere, O
    Pangaud, C
    Lyonnet, D
    Dubernard, JM
    PROGRES EN UROLOGIE, 2003, 13 (01): : 60 - 72
  • [5] Clinical Significance of Free-to-Total Prostate-Specific Antigen (PSA) Ratio in Advanced Prostate Cancer Patients with PSA Less than 0.1 ng/ml after Hormone Treatment
    Kim, Dae Il
    Song, Jae Mann
    Chung, Hyun Chul
    KOREAN JOURNAL OF UROLOGY, 2012, 53 (03) : 149 - 153
  • [6] Predictive values for extracapsular extension in prostate cancer patients with PSA values below 10 ng/mL
    Sertkaya, Zulfu
    Ozturk, Metin Ishak
    Koca, Orhan
    Gunes, Mustafa
    Karaman, Muhammet Ihsan
    TURKISH JOURNAL OF UROLOGY, 2014, 40 (03): : 130 - 133
  • [7] Is free/total PSA predictive of pathological stage and Gleason score in patients with prostate cancer and serum PSA ≤10 ng/ml?
    Pepe, P
    Panella, P
    Pietropaolo, F
    Pennisi, M
    Allegro, R
    Aragona, F
    UROLOGIA INTERNATIONALIS, 2006, 76 (03) : 232 - 235
  • [8] Post-treatment PSA ≤0.2 ng/mL defines disease freedom after radiotherapy for prostate cancer using modern techniques
    Critz, FA
    Williams, WH
    Holladay, CT
    Levinson, AK
    Benton, JB
    Holladay, DA
    Schnell, FJ
    Maxa, LS
    Shrake, PD
    UROLOGY, 1999, 54 (06) : 968 - 971
  • [9] Achieving an undetectable PSA <0.1ng/ml following SRT predicts the outcome of patients receiving SRT for biochemical recurrence following RP
    Scharl, Sophia
    Gartner, Luca
    Boehmer, Dirk
    Siegmann, Alessandra
    Zips, Daniel
    Thamm, Reinhard
    Krafcsik, Manuel
    Mayer, Benjamin
    Wiegel, Thomas
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 86 - 86
  • [10] Better Prognosis by early Salvage Radiotherapy (PSA &lt;0.2 ng/ml) in PSA-Progression after Prostate Cancer Surgery
    Thamm, R.
    Bartkowiak, D.
    Bottke, D.
    Siegmann, A.
    Boehmer, D.
    Budach, V
    Wiegel, T.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 : 40 - 40
12345